category	number_of_genes	p_value	fdr	description
NetworkNeighborAL	43	1.52e-84	6.96e-81	DNA replication, and Regulation of DNA-directed DNA polymerase activity
Process	47	3.04e-74	4.7700000000000006e-70	DNA replication
RCTM	43	8.240000000000001e-71	1.88e-67	Mitotic G1 phase and G1/S transition
RCTM	41	2.06e-68	2.35e-65	G1/S Transition
RCTM	42	3.76e-67	2.86e-64	S Phase
Process	41	1.32e-67	1.03e-63	DNA-templated DNA replication
RCTM	41	1.3800000000000001e-65	7.899999999999999e-63	DNA Replication
RCTM	50	5.56e-62	2.54e-59	Cell Cycle, Mitotic
RCTM	37	7.94e-61	3.0200000000000003e-58	Synthesis of DNA
Keyword	35	3.3900000000000003e-59	2.2800000000000003e-56	DNA replication
Process	53	3.56e-59	1.86e-55	DNA metabolic process
RCTM	29	2.15e-57	7.01e-55	Activation of the pre-replicative complex
PMID	31	3e-57	1.32e-50	(2020) Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma.
WikiPathways	28	6.92e-53	5.41e-50	DNA replication
WikiPathways	29	5.09e-51	1.99e-48	G1 to S cell cycle control
NetworkNeighborAL	26	1.95e-51	4.4499999999999995e-48	Activation of the pre-replicative complex, and GINS complex
WikiPathways	31	2.81e-48	7.299999999999999e-46	Cell cycle
KEGG	31	2.81e-48	9.43e-46	Cell cycle
Process	60	3.29e-47	1.29e-43	Nucleic acid metabolic process
Process	22	3.01e-42	9.45e-39	DNA replication initiation
COMPARTMENTS	34	2.58e-41	5.94e-38	Nuclear chromosome
WikiPathways	25	1.31e-39	2.55e-37	Retinoblastoma gene in cancer
COMPARTMENTS	53	2.8e-40	3.2200000000000003e-37	Nuclear lumen
Component	31	1.24e-39	2.53e-36	Nuclear chromosome
Process	57	3.15e-39	5.4800000000000004e-36	Cellular macromolecule metabolic process
COMPARTMENTS	43	1.21e-38	9.27e-36	Chromosome
RCTM	23	2.91e-35	6.65e-33	Switching of origins to a post-replicative state
PMID	24	4.47e-39	9.78e-33	(2018) Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated with Melicope ptelefolia leaf extract reveals transcriptome profiles exhibiting anticancer activity.
PMID	22	1.59e-38	2.32e-32	(2021) Congenital Diseases of DNA Replication: Clinical Phenotypes and Molecular Mechanisms.
COMPARTMENTS	27	4.910000000000001e-35	2.82e-32	protein-DNA complex
Process	25	2.6e-35	3.4000000000000003e-32	Regulation of DNA replication
RCTM	19	5.25e-34	1.09e-31	Activation of ATR in response to replication stress
PMID	20	1.5e-37	1.6400000000000001e-31	(2021) Systemic Analysis of the DNA Replication Regulator MCM Complex in Ovarian Cancer and Its Prognostic Value.
Component	17	1.63e-33	1.67e-30	DNA polymerase complex
PMID	20	3.79e-36	3.32e-30	(2017) Integrated genome and transcriptome sequencing identifies a noncoding mutation in the genome replication factor DONSON as the cause of microcephaly-micromelia syndrome.
COMPARTMENTS	17	9.6e-33	4.4199999999999995e-30	DNA polymerase complex
PMID	20	8.720000000000001e-36	6.36e-30	(2020) MCMs in Cancer: Prognostic Potential and Mechanisms.
COMPARTMENTS	63	6.170000000000001e-32	2.3600000000000002e-29	Nucleus
COMPARTMENTS	16	8.28e-32	2.72e-29	DNA replication preinitiation complex
RCTM	20	1.48e-31	2.81e-29	Orc1 removal from chromatin
COMPARTMENTS	54	9.83e-32	2.83e-29	Intracellular organelle lumen
PMID	21	5.52e-35	3.4600000000000003e-29	(2017) The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.
PMID	18	2.9899999999999998e-34	1.64e-28	(2017) From structure to mechanism-understanding initiation of DNA replication.
RCTM	17	1.19e-30	2.09e-28	DNA strand elongation
Process	66	1.76e-31	2.13e-28	Macromolecule metabolic process
KEGG	17	5.8699999999999996e-30	9.859999999999999e-28	DNA replication
Component	61	1.58e-30	1.0800000000000001e-27	Nuclear lumen
Component	59	7.249999999999999e-30	3.7100000000000005e-27	Nucleoplasm
PMID	18	1.3500000000000002e-32	6.55e-27	(2009) Replication licensing and the DNA damage checkpoint.
COMPARTMENTS	63	3.91e-29	8.18e-27	Protein-containing complex
Process	31	1.0400000000000001e-29	1.16e-26	Mitotic cell cycle process
Component	26	5.58e-29	2.29e-26	Transferase complex, transferring phosphorus-containing groups
RCTM	25	2.18e-28	3.55e-26	Cell Cycle Checkpoints
Process	18	4.35e-29	4.5500000000000003e-26	Regulation of DNA-templated DNA replication
Process	32	4.6400000000000004e-29	4.5500000000000003e-26	Mitotic cell cycle
COMPARTMENTS	26	3.37e-28	6.47e-26	Transferase complex, transferring phosphorus-containing groups
Process	39	1.38e-28	1.27e-25	Cell cycle
PMID	20	3.88e-31	1.7e-25	(2018) Control of DNA Replication Initiation by Ubiquitin.
Process	33	2.95e-28	2.57e-25	Cellular response to DNA damage stimulus
PMID	17	7.810000000000001e-31	3.11e-25	(2008) Butyrate induced cell cycle arrest in bovine cells through targeting gene expression relevant to DNA replication apparatus.
COMPARTMENTS	37	2.4100000000000003e-27	4.27e-25	Nucleoplasm
Process	66	6.4699999999999995e-28	5.34e-25	Cellular metabolic process
PMID	18	1.68e-30	6.14e-25	(2020) Molecular mechanisms of eukaryotic origin initiation, replication fork progression, and chromatin maintenance.
PMID	21	2.38e-30	8.03e-25	(2020) Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.
Process	66	1.34e-27	1.05e-24	Nitrogen compound metabolic process
Component	43	5.8e-27	1.98e-24	Chromosome
PMID	17	1.2300000000000001e-29	3.86e-24	(2018) The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy.
RCTM	14	3.49e-26	5.31e-24	E2F mediated regulation of DNA replication
PMID	16	1.8300000000000002e-29	5.35e-24	(2020) Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Process	29	8.710000000000001e-27	6.5099999999999996e-24	Regulation of DNA metabolic process
Process	33	1.04e-26	7.41e-24	Cell cycle process
Component	62	3.46e-26	1.0099999999999999e-23	Intracellular organelle lumen
PMID	16	4.45e-29	1.2199999999999999e-23	(2020) MCM10 Acts as a Potential Prognostic Biomarker and Promotes Cell Proliferation in Hepatocellular Carcinoma: Integrated Bioinformatics Analysis and Experimental Validation.
Process	28	2.2600000000000002e-26	1.54e-23	DNA repair
RCTM	20	1.11e-25	1.5799999999999998e-23	G2/M Checkpoints
PMID	19	6.3e-29	1.62e-23	(2012) Transcriptome characterization by RNA-seq unravels the mechanisms of butyrate-induced epigenomic regulation in bovine cells.
Component	37	1.41e-25	2.9e-23	Nuclear protein-containing complex
PMID	15	1.43e-28	3.48e-23	(2020) Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
PMID	16	2.28e-28	5.2599999999999997e-23	(2019) Preparation for DNA replication: the key to a successful S phase.
Component	32	3.1e-25	5.759999999999999e-23	Transferase complex
PMID	16	3.35e-28	7.319999999999999e-23	(2016) Regulation and Function of Cdt1; A Key Factor in Cell Proliferation and Genome Stability.
NetworkNeighborAL	13	6.640000000000001e-26	1.01e-22	CDC6 association with the ORC:origin complex, and Double-strand break repair via break-induced replication
Process	66	1.58e-25	1.0300000000000001e-22	Primary metabolic process
PMID	16	1e-27	2.0900000000000002e-22	(2012) Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication.
PMID	16	1e-27	2.0900000000000002e-22	(2020) The replisome guides nucleosome assembly during DNA replication.
PMID	15	1.02e-27	2.0900000000000002e-22	(2021) The CRK2-CYC13 complex functions as an S-phase cyclin-dependent kinase to promote DNA replication in Trypanosoma brucei.
COMPARTMENTS	32	1.45e-24	2.38e-22	Transferase complex
PMID	14	1.3600000000000002e-27	2.48e-22	(2014) DNA binding polarity, dimerization, and ATPase ring remodeling in the CMG helicase of the eukaryotic replisome.
PMID	16	2e-27	3.5000000000000005e-22	(2012) Emerging players in the initiation of eukaryotic DNA replication.
PMID	14	2.47e-27	4.16e-22	(2017) Structural basis of Mcm2-7 replicative helicase loading by ORC-Cdc6 and Cdt1.
NetworkNeighborAL	14	4.78e-25	5.47e-22	Polymerase switching, and Epsilon DNA polymerase complex
COMPARTMENTS	50	3.6499999999999996e-24	5.600000000000001e-22	Intracellular non-membrane-bounded organelle
PMID	15	5.78e-27	9.38e-22	(2017) Mechanisms and regulation of DNA replication initiation in eukaryotes.
PMID	14	7.580000000000001e-27	1.19e-21	(2020) Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
PMID	16	9.910000000000001e-27	1.5e-21	(2014) Molecular mechanisms of DNA replication checkpoint activation.
PMID	14	1.2900000000000001e-26	1.88e-21	(2013) Mechanisms for initiating cellular DNA replication.
NetworkNeighborAL	14	3.0499999999999998e-24	2.79e-21	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3), and Cyclin-dependent protein serine/threonine kinase regulator activity
Process	67	5.41e-24	3.2600000000000002e-21	Metabolic process
PMID	14	3.49e-26	4.9300000000000006e-21	(2012) Structural biology of replication initiation factor Mcm10.
PMID	14	3.49e-26	4.9300000000000006e-21	(2012) Identification of ORC1CDC6-interacting factors in Trypanosoma brucei reveals critical features of origin recognition complex architecture.
PMID	15	5.57e-26	7.4e-21	(2017) ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
NetworkNeighborAL	12	1.1099999999999999e-23	8.44e-21	DNA polymerase complex
Keyword	28	2.6099999999999997e-23	8.78e-21	Cell cycle
PMID	17	8.260000000000001e-26	1.06e-20	(2019) Comparative RNA-seq analysis reveals dys-regulation of major canonical pathways in ERG-inducible LNCaP cell progression model of prostate cancer.
PMID	14	8.84e-26	1.11e-20	(2020) DNA replication protein Cdc45 directly interacts with PCNA via its PIP box in Leishmania donovani and the Cdc45 PIP box is essential for cell survival.
PMID	16	9.54e-26	1.16e-20	(2019) Post-Translational Modifications of the Mini-Chromosome Maintenance Proteins in DNA Replication.
Keyword	58	5.2e-23	1.16e-20	Nucleus
PMID	16	9.54e-26	1.16e-20	(2018) miRNA involvement in cell cycle regulation in colorectal cancer cases.
PMID	17	1.02e-25	1.18e-20	(2010) An overview of Cdk1-controlled targets and processes.
PMID	13	1.24e-25	1.39e-20	(2022) Novel Compound Heterozygous Variants in the CDC6 Gene in a Russian Patient with Meier-Gorlin Syndrome.
PMID	16	1.24e-25	1.39e-20	(2018) Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators.
PMID	14	1.38e-25	1.47e-20	(2020) The DNA replication fork suppresses CMG unloading from chromatin before termination.
PMID	16	2.06e-25	2.15e-20	(2019) CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
PMID	13	2.23e-25	2.27e-20	(2017) High throughput estimation of functional cell activities reveals disease mechanisms and predicts relevant clinical outcomes.
NetworkNeighborAL	13	3.85e-23	2.51e-20	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3), and Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
PMID	16	2.65e-25	2.63e-20	(2011) The dynamics of E1A in regulating networks and canonical pathways in quiescent cells.
PMID	14	3.1999999999999997e-25	3.11e-20	(2012) Genome wide comparative comprehensive analysis of Plasmodium falciparum MCM family with human host.
PMID	14	3.1999999999999997e-25	3.11e-20	(2017) Human RIF1 and protein phosphatase 1 stimulate DNA replication origin licensing but suppress origin activation.
PMID	13	3.93e-25	3.66e-20	(2017) Eukaryotic Replicative Helicase Subunit Interaction with DNA and Its Role in DNA Replication.
PMID	14	4.78e-25	4.36e-20	(2021) Regulation of DNA Replication Licensing and Re-Replication by Cdt1.
Component	65	3.51e-22	5.98e-20	Nucleus
PMID	13	6.75e-25	6.03e-20	(2021) Role of Amygdalin in Blocking DNA Replication in Breast Cancer In Vitro.
RCTM	11	5.31e-22	7.12e-20	Unwinding of DNA
Component	11	5.31e-22	7.92e-20	DNA replication preinitiation complex
Component	58	5.0300000000000005e-22	7.92e-20	Protein-containing complex
PMID	16	1.09e-24	9.53e-20	(2019) Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition.
PMID	13	1.13e-24	9.74e-20	(2018) MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes SG2 cell cycle progression.
PMID	16	1.36e-24	1.15e-19	(2016) Chromosome Duplication in Saccharomyces cerevisiae.
COMPARTMENTS	11	9.77e-22	1.32e-19	MCM complex
PMID	13	1.87e-24	1.54e-19	(2017) Mcm10 regulates DNA replication elongation by stimulating the CMG replicative helicase.
PMID	16	2.11e-24	1.71e-19	(2019) Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.
PMID	14	2.1499999999999998e-24	1.71e-19	(2021) Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes.
PMID	15	2.23e-24	1.75e-19	(2019) Cell type specific transcriptional reprogramming of maize leaves during Ustilago maydis induced tumor formation.
PMID	15	2.9299999999999998e-24	2.25e-19	(2021) The human origin recognition complex is essential for pre-RC assembly, mitosis, and maintenance of nuclear structure.
PMID	13	3.01e-24	2.28e-19	(2020) PRIM1 deficiency causes a distinctive primordial dwarfism syndrome.
PMID	13	3.01e-24	2.28e-19	(2004) Deregulation of cyclin E in human cells interferes with prereplication complex assembly.
PMID	15	3.81e-24	2.78e-19	(2021) Knockdown of MCM8 functions as a strategy to inhibit the development and progression of osteosarcoma through regulating CTGF.
PMID	14	4.2999999999999996e-24	3.08e-19	(2021) Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
PMID	15	8.199999999999999e-24	5.79e-19	(2021) Ubiquitin signaling in cell cycle control and tumorigenesis.
RCTM	16	4.57e-21	5.79e-19	Assembly of the pre-replicative complex
Component	19	7.78e-21	1.06e-18	protein-DNA complex
PMID	13	1.74e-23	1.21e-18	(2015) Regulated eukaryotic DNA replication origin firing with purified proteins.
PMID	14	2.1099999999999998e-23	1.45e-18	(2020) RPL21 siRNA Blocks Proliferation in Pancreatic Cancer Cells by Inhibiting DNA Replication and Inducing G1 Arrest and Apoptosis.
PMID	13	2.6e-23	1.75e-18	(2019) Control of Eukaryotic DNA Replication Initiation-Mechanisms to Ensure Smooth Transitions.
PMID	17	3.3899999999999994e-23	2.25e-18	(2011) The retroviral cyclin of walleye dermal sarcoma virus binds cyclin-dependent kinases 3 and 8.
PMID	12	3.47e-23	2.27e-18	(2009) Concerted loading of Mcm2-7 double hexamers around DNA during DNA replication origin licensing.
PMID	12	3.47e-23	2.27e-18	(2018) A structural view of the initiators for chromosome replication.
PMID	15	4.25e-23	2.69e-18	(2012) DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of earlymid-stage non-small cell lung cancer patients.
PMID	13	5.62e-23	3.51e-18	(2017) Regulation of DNA Replication in Early Embryonic Cleavages.
PMID	13	5.62e-23	3.51e-18	(2019) TGFbeta1 Cell Cycle Arrest Is Mediated by Inhibition of MCM Assembly in Rb-Deficient Conditions.
PMID	12	5.9e-23	3.59e-18	(2021) DDK regulates replication initiation by controlling the multiplicity of Cdc45-GINS binding to Mcm2-7.
PMID	12	5.9e-23	3.59e-18	(2020) CryoEM structures of human CMG-ATPgammaS-DNA and CMG-AND-1 complexes.
PMID	12	5.9e-23	3.59e-18	(2014) Geminin inhibits a late step in the formation of human pre-replicative complexes.
PMID	13	8.11e-23	4.74e-18	(2020) The DNA polymerases of Drosophila melanogaster.
Component	55	3.91e-20	5.01e-18	Intracellular non-membrane-bounded organelle
Process	15	8.82e-21	5.12e-18	Cell cycle G1/S phase transition
Component	10	4.65e-20	5.28e-18	CMG complex
PMID	12	9.809999999999999e-23	5.65e-18	(2016) An Mcm10 Mutant Defective in ssDNA Binding Shows Defects in DNA Replication Initiation.
COMPARTMENTS	10	4.65e-20	5.94e-18	CMG complex
PMID	12	1.6000000000000002e-22	9.07e-18	(2014) A unique DNA entry gate serves for regulated loading of the eukaryotic replicative helicase MCM2-7 onto DNA.
PMID	13	1.64e-22	9.22e-18	(2016) A Role of hIPI3 in DNA Replication Licensing in Human Cells.
PMID	13	1.64e-22	9.22e-18	(2020) Novel candidate biomarkers of origin recognition complex 1, 5 and 6 for survival surveillance in patients with hepatocellular carcinoma.
Process	35	1.83e-20	1.02e-17	Cellular response to stress
PMID	15	1.86e-22	1.02e-17	(2017) Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.
PMID	14	1.94e-22	1.05e-17	(2019) Time varying causal network reconstruction of a mouse cell cycle.
Component	34	1.08e-19	1.17e-17	Catalytic complex
PMID	13	2.3000000000000003e-22	1.23e-17	(2021) Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
PMID	13	3.2000000000000003e-22	1.69e-17	(2017) Lamin B2 binding to minichromosome maintenance complex component 7 promotes non-small cell lung carcinogenesis.
PMID	13	3.2000000000000003e-22	1.69e-17	(2013) Screening of feature genes of the ovarian cancer epithelia with DNA microarray.
PMID	12	3.99e-22	2.06e-17	(2013) Activation of a human chromosomal replication origin by protein tethering.
PMID	14	4.0900000000000002e-22	2.08e-17	(2009) Evidence that human blastomere cleavage is under unique cell cycle control.
PMID	14	4.0900000000000002e-22	2.08e-17	(2013) The replication fork: understanding the eukaryotic replication machinery and the challenges to genome duplication.
PMID	11	5.31e-22	2.64e-17	(2014) Minichromosome Maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas.
PMID	13	6.0400000000000005e-22	2.97e-17	(2017) CRL4B(DCAF11) E3 ligase targets p21 for degradation to control cell cycle progression in human osteosarcoma cells.
PMID	12	6.15e-22	2.99e-17	(2017) Potent DNA strand annealing activity associated with mouse Mcm2~7 heterohexameric complex.
PMID	12	6.15e-22	2.99e-17	(2009) Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication.
COMPARTMENTS	35	2.62e-19	3.17e-17	Catalytic complex
COMPARTMENTS	64	3.03e-19	3.48e-17	Intracellular membrane-bounded organelle
PMID	13	8.200000000000001e-22	3.9e-17	(2021) Transcriptome Analysis of Caco-2 Cells upon the Exposure of Mycotoxin Deoxynivalenol and Its Acetylated Derivatives.
Process	10	8.49e-20	4.59e-17	Double-strand break repair via break-induced replication
PMID	11	9.77e-22	4.6e-17	(2020) Tissue-Specific DNA Replication Defects in Drosophila melanogaster Caused by a Meier-Gorlin Syndrome Mutation in Orc4.
PMID	11	9.77e-22	4.6e-17	(2009) Ancient diversification of eukaryotic MCM DNA replication proteins.
PMID	14	1.04e-21	4.8e-17	(2021) Role of Hypoxia in the Control of the Cell Cycle.
Process	17	9.51e-20	4.97e-17	Mitotic cell cycle phase transition
PMID	13	1.1e-21	5.04e-17	(2021) Structure of a human replisome shows the organisation and interactions of a DNA replication machine.
PMID	13	1.1e-21	5.04e-17	(2018) Regulation of the initiation of DNA replication in human cells.
PMID	12	1.4e-21	6.24e-17	(2016) The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
PMID	12	1.4e-21	6.24e-17	(2011) CDK promotes interactions of Sld3 and Drc1 with Cut5 for initiation of DNA replication in fission yeast.
PMID	12	1.4e-21	6.24e-17	(2016) The presence of extra chromosomes leads to genomic instability.
COMPARTMENTS	13	9.06e-19	9.49e-17	Replication fork
COMPARTMENTS	11	8.66e-19	9.49e-17	Replisome
Process	14	3.44e-19	1.68e-16	G1/S transition of mitotic cell cycle
InterPro	10	2.44e-20	1.75e-16	Mini-chromosome maintenance protein
InterPro	10	2.44e-20	1.75e-16	MCM, AAA-lid domain
InterPro	10	2.44e-20	1.75e-16	MCM domain
Process	10	4.26e-19	2.02e-16	Regulation of DNA-templated DNA replication initiation
Process	14	5.31e-19	2.45e-16	DNA duplex unwinding
COMPARTMENTS	9	4.02e-18	4.02e-16	GINS complex
Function	18	1.59e-19	7.86e-16	Catalytic activity, acting on DNA
Function	10	6.9e-19	1.7e-15	DNA replication origin binding
NetworkNeighborAL	10	5.69e-18	2.36e-15	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3), and Cyclin-dependent protein serine/threonine kinase inhibitor activity
Process	10	8.25e-18	3.5e-15	DNA unwinding involved in DNA replication
InterPro	9	2.12e-18	3.81e-15	MCM OB domain
Process	14	1.26e-17	5.19e-15	Double-strand break repair via homologous recombination
Component	9	5.61e-17	5.74e-15	Replisome
Process	10	1.67e-17	6.7e-15	Nuclear DNA replication
Component	10	7.97e-17	7.77e-15	Nuclear replication fork
Component	24	1.36e-16	1.27e-14	Intracellular protein-containing complex
Process	16	3.63e-17	1.36e-14	Double-strand break repair
Process	13	3.76e-17	1.37e-14	DNA biosynthetic process
Component	8	1.82e-16	1.62e-14	MCM complex
COMPARTMENTS	10	1.83e-16	1.76e-14	Nuclear replication fork
Component	14	2.34e-16	2e-14	Chromosome, telomeric region
Process	9	5.61e-17	2e-14	DNA strand elongation involved in DNA replication
RCTM	8	1.82e-16	2.19e-14	DNA replication initiation
RCTM	8	1.82e-16	2.19e-14	CDC6 association with the ORC:origin complex
RCTM	8	3.43e-16	3.73e-14	E2F-enabled inhibition of pre-replication complex formation
NetworkNeighborAL	8	1.82e-16	6.95e-14	DNA replication initiation
Component	11	8.83e-16	7.23e-14	Replication fork
COMPARTMENTS	8	1.06e-15	9.4e-14	Origin recognition complex
NetworkNeighborAL	8	6.16e-16	2.17e-13	CMG complex, and Replication fork arrest
Component	8	2.84e-15	2.24e-13	Nuclear replisome
Process	19	6.83e-16	2.33e-13	Regulation of cell cycle phase transition
RCTM	9	3.91e-15	4.06e-13	G0 and Early G1
RCTM	10	5.16e-15	5.11e-13	Cyclin D associated events in G1
RCTM	9	5.15e-15	5.11e-13	G1/S-Specific Transcription
RCTM	10	6.22e-15	5.46e-13	DNA Damage Bypass
WikiPathways	11	4.69e-15	7.32e-13	miRNA regulation of DNA damage response
Process	26	2.61e-15	8.7e-13	Regulation of cell cycle
Process	17	2.77e-15	9.04e-13	Regulation of mitotic cell cycle phase transition
Process	12	3.6e-15	1.15e-12	Regulation of G2/M transition of mitotic cell cycle
Process	24	3.73e-15	1.17e-12	Nucleobase-containing compound biosynthetic process
RCTM	8	1.49e-14	1.26e-12	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
KEGG	13	1.3e-14	1.46e-12	Cellular senescence
RCTM	11	1.98e-14	1.56e-12	Cyclin E associated events during G1/S transition
COMPARTMENTS	8	2.15e-14	1.77e-12	Nuclear replisome
RCTM	11	2.52e-14	1.92e-12	Cyclin A:Cdk2-associated events at S phase entry
Function	9	1.18e-15	1.94e-12	DNA-directed DNA polymerase activity
RCTM	9	3.59e-14	2.64e-12	Aberrant regulation of mitotic cell cycle due to RB1 defects
WikiPathways	11	2.52e-14	3.28e-12	Pyrimidine metabolism
Component	7	5.15e-14	3.9e-12	Nuclear origin of replication recognition complex
NetworkNeighborAL	7	1.55e-14	5.08e-12	CDC6 association with the ORC:origin complex
Function	36	4.27e-15	5.26e-12	DNA binding
Function	20	7.94e-15	6.53e-12	Catalytic activity, acting on a nucleic acid
Component	16	2e-13	1.41e-11	Chromosomal region
WikiPathways	10	1.62e-13	1.81e-11	DNA damage response
NetworkNeighborAL	7	8.73e-14	2.66e-11	Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
COMPARTMENTS	9	3.53e-13	2.7e-11	Cyclin-dependent protein kinase holoenzyme complex
Process	18	1.01e-13	2.92e-11	Regulation of mitotic cell cycle
RCTM	7	5.16e-13	3.57e-11	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
Process	23	1.31e-13	3.73e-11	Chromosome organization
RCTM	9	5.75e-13	3.86e-11	Extension of Telomeres
Component	9	5.75e-13	3.92e-11	Cyclin-dependent protein kinase holoenzyme complex
RCTM	8	6.52e-13	4.25e-11	Recognition of DNA damage by PCNA-containing replication complex
Process	16	1.57e-13	4.32e-11	Negative regulation of cell cycle
Process	7	2.25e-13	6.08e-11	Mitotic DNA replication
InterPro	11	4.51e-14	6.48e-11	Nucleic acid-binding, OB-fold
TISSUES	16	3.16e-14	7.66e-11	Cervical carcinoma cell
COMPARTMENTS	66	1.72e-12	1.28e-10	Intracellular
Process	11	5.05e-13	1.32e-10	DNA integrity checkpoint signaling
DISEASES	8	3.05e-14	1.4e-10	Retinal cancer
Process	12	5.94e-13	1.53e-10	Cell cycle checkpoint signaling
RCTM	8	4.09e-12	2.59e-10	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template
KEGG	12	3.26e-12	2.74e-10	Viral carcinogenesis
COMPARTMENTS	6	4.25e-12	3.06e-10	Nuclear origin of replication recognition complex
DISEASES	7	1.42e-13	3.27e-10	Meier-Gorlin syndrome
Process	13	1.71e-12	4.33e-10	Negative regulation of cell cycle phase transition
COMPARTMENTS	6	7.07e-12	4.93e-10	Pre-replicative complex
Function	11	7.84e-13	5.52e-10	Nucleotidyltransferase activity
Function	11	9.3e-13	5.73e-10	Single-stranded DNA binding
KEGG	9	9.57e-12	6.43e-10	p53 signaling pathway
KEGG	8	1.33e-11	7.43e-10	Nucleotide excision repair
Process	17	3.69e-12	9.18e-10	Cell division
DISEASES	7	1.08e-12	1.24e-09	Retinoblastoma
RCTM	11	2.1e-11	1.29e-09	Cellular Senescence
RCTM	8	2.09e-11	1.29e-09	TP53 Regulates Transcription of Cell Cycle Genes
Process	8	5.83e-12	1.41e-09	DNA synthesis involved in DNA repair
Process	37	6.03e-12	1.43e-09	Response to stress
KEGG	16	3.02e-11	1.45e-09	Pathways in cancer
InterPro	6	1.32e-12	1.57e-09	MCM N-terminal domain
InterPro	6	1.32e-12	1.57e-09	Mini-chromosome maintenance, conserved site
Function	9	3.2e-12	1.75e-09	DNA helicase activity
RCTM	6	3.79e-11	2.22e-09	Inhibition of replication initiation of damaged DNA by RB1/E2F1
Function	21	5.11e-12	2.52e-09	Transferase activity, transferring phosphorus-containing groups
KEGG	9	7.25e-11	3.05e-09	Small cell lung cancer
RCTM	6	5.4e-11	3.08e-09	Polymerase switching
RCTM	6	5.4e-11	3.08e-09	Removal of the Flap Intermediate
Component	66	4.72e-11	3.12e-09	Intracellular membrane-bounded organelle
RCTM	8	8.03e-11	4.1e-09	SCF(Skp2)-mediated degradation of p27/p21
RCTM	13	7.91e-11	4.1e-09	DNA Repair
KEGG	11	1.11e-10	4.13e-09	Epstein-Barr virus infection
Keyword	28	3.05e-11	5.13e-09	DNA-binding
Component	5	1.11e-10	7.11e-09	Epsilon DNA polymerase complex
Component	5	1.11e-10	7.11e-09	Alpha DNA polymerase:primase complex
COMPARTMENTS	5	1.11e-10	7.52e-09	Alpha DNA polymerase:primase complex
COMPARTMENTS	5	1.11e-10	7.52e-09	Epsilon DNA polymerase complex
HPO	7	7.55e-13	9.21e-09	Breast aplasia
Keyword	14	8.66e-11	1.09e-08	DNA damage
Keyword	14	8.11e-11	1.09e-08	Cell division
RCTM	7	3.04e-10	1.47e-08	Dual Incision in GG-NER
Process	9	7.25e-11	1.67e-08	Positive regulation of mitotic cell cycle phase transition
RCTM	9	4e-10	1.86e-08	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)
RCTM	6	4.05e-10	1.86e-08	PCNA-Dependent Long Patch Base Excision Repair
Function	39	4.84e-11	2.17e-08	Nucleic acid binding
HPO	7	3.88e-12	2.37e-08	Patellar aplasia
Process	5	1.11e-10	2.53e-08	Positive regulation of DNA primase activity
Process	5	1.11e-10	2.53e-08	Mitotic DNA replication initiation
NetworkNeighborAL	5	1.11e-10	3.18e-08	GINS complex, and Minichromosome  maintenance proteins
Process	23	1.93e-10	4.04e-08	Macromolecule biosynthetic process
Keyword	54	4.3e-10	4.13e-08	Phosphoprotein
RCTM	6	9.95e-10	4.29e-08	Gap-filling DNA repair synthesis and ligation in GG-NER
HPO	6	1.13e-11	4.59e-08	Microtia, third degree
WikiPathways	7	4.73e-10	4.62e-08	Integrated cancer pathway
WikiPathways	7	4.73e-10	4.62e-08	Nucleotide excision repair
WikiPathways	6	6.46e-10	5.04e-08	DNA mismatch repair
RCTM	6	1.22e-09	5.07e-08	Polymerase switching on the C-strand of the telomere
HPO	6	1.74e-11	5.3e-08	Anotia
NetworkNeighborAL	5	2.03e-10	5.47e-08	Double-strand break repair via break-induced replication
WikiPathways	8	8.96e-10	6.36e-08	Glioblastoma signaling pathways
HPO	6	5.4e-11	1.1e-07	Mandibular aplasia
Process	10	5.53e-10	1.13e-07	Negative regulation of mitotic cell cycle phase transition
RCTM	7	3.4e-09	1.39e-07	DNA Damage/Telomere Stress Induced Senescence
KEGG	9	4.96e-09	1.45e-07	Cushing syndrome
KEGG	10	4.55e-09	1.45e-07	Human T-cell leukemia virus 1 infection
KEGG	6	4.32e-09	1.45e-07	Base excision repair
RCTM	6	3.66e-09	1.47e-07	Termination of translesion DNA synthesis
Keyword	12	1.83e-09	1.54e-07	DNA repair
WikiPathways	8	2.65e-09	1.73e-07	Small cell lung cancer
Process	12	8.83e-10	1.75e-07	Positive regulation of DNA metabolic process
WikiPathways	6	3.09e-09	1.86e-07	Base excision repair
Process	6	9.95e-10	1.95e-07	Translesion synthesis
RCTM	7	5.15e-09	1.96e-07	Gap-filling DNA repair synthesis and ligation in TC-NER
Process	7	1.06e-09	2.05e-07	Mitotic G2/M transition checkpoint
Process	9	1.06e-09	2.05e-07	Mitotic cell cycle checkpoint signaling
RCTM	7	5.69e-09	2.13e-07	Dual incision in TC-NER
RCTM	16	5.87e-09	2.16e-07	Cellular responses to stress
Process	8	1.17e-09	2.21e-07	Mitotic DNA integrity checkpoint signaling
RCTM	7	6.27e-09	2.27e-07	G1/S DNA Damage Checkpoints
Function	46	6e-10	2.28e-07	Heterocyclic compound binding
HPO	6	1.39e-10	2.43e-07	Aplastic clavicle
Process	5	1.31e-09	2.44e-07	Error-prone translesion synthesis
Function	7	8.21e-10	2.89e-07	Cyclin-dependent protein serine/threonine kinase regulator activity
WikiPathways	10	5.41e-09	3.02e-07	Ciliary landscape
Function	46	9.31e-10	3.06e-07	Organic cyclic compound binding
RCTM	4	9.41e-09	3.23e-07	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
RCTM	6	9.21e-09	3.23e-07	Assembly of the ORC complex at the origin of replication
Process	9	1.76e-09	3.24e-07	Signal transduction in response to DNA damage
WikiPathways	5	6.65e-09	3.46e-07	miRNAs involved in DNA damage response
Component	4	9.41e-09	5.07e-07	GINS complex
Component	4	9.41e-09	5.07e-07	Zeta DNA polymerase complex
RCTM	4	1.69e-08	5.67e-07	G2 Phase
COMPARTMENTS	4	9.41e-09	5.7e-07	Zeta DNA polymerase complex
Keyword	5	8.71e-09	6.5e-07	DNA-directed DNA polymerase
Process	5	3.7e-09	6.74e-07	Positive regulation of DNA-directed DNA polymerase activity
WikiPathways	8	1.49e-08	6.97e-07	DNA repair pathways, full network
WikiPathways	7	1.43e-08	6.97e-07	Nucleotide excision repair in xeroderma pigmentosum 
RCTM	7	2.34e-08	7.65e-07	Senescence-Associated Secretory Phenotype (SASP)
HPO	6	5.13e-10	7.83e-07	Hypoplastic labia minora
HPO	6	6.46e-10	8.75e-07	Epispadias
Process	8	5.55e-09	9.67e-07	DNA damage checkpoint signaling
HPO	6	8.05e-10	9.82e-07	Clitoral hypoplasia
Keyword	32	1.74e-08	1.17e-06	Acetylation
Process	36	8.13e-09	1.37e-06	Regulation of nucleobase-containing compound metabolic process
Process	8	8.37e-09	1.4e-06	Regulation of cyclin-dependent protein serine/threonine kinase activity
SMART	9	1.76e-09	1.44e-06	ATPases associated with a variety of cellular activities
COMPARTMENTS	4	2.81e-08	1.66e-06	Dbf4-dependent protein kinase complex
Process	43	1.15e-08	1.88e-06	Regulation of nitrogen compound metabolic process
RCTM	5	5.95e-08	1.89e-06	Cyclin A/B1/B2 associated events during G2/M transition
Process	17	1.37e-08	2.21e-06	Regulation of transferase activity
WikiPathways	4	6.59e-08	2.86e-06	Hijack of ubiquitination by SARS-CoV-2
KEGG	8	1.13e-07	2.92e-06	Hepatitis B
Keyword	8	4.89e-08	2.99e-06	Helicase
Process	45	2.22e-08	3.55e-06	Cellular response to stimulus
Process	10	2.32e-08	3.68e-06	Positive regulation of cell cycle process
TISSUES	19	3.28e-09	3.98e-06	Leukemia cell
WikiPathways	5	9.84e-08	4.04e-06	Sphingolipid metabolism in senescence
NetworkNeighborAL	4	1.69e-08	4.3e-06	Cyclin E1-CDK2 complex, and Omphalocele
NetworkNeighborAL	4	1.69e-08	4.3e-06	VCB complex, and VHL beta domain
TISSUES	20	5.57e-09	4.5e-06	Blood cancer cell
Process	43	2.89e-08	4.54e-06	Regulation of primary metabolic process
RCTM	18	1.48e-07	4.63e-06	Generic Transcription Pathway
RCTM	6	1.59e-07	4.92e-06	p53-Dependent G1 DNA Damage Response
WikiPathways	6	1.34e-07	5.22e-06	Prader-Willi and Angelman syndrome
KEGG	10	2.33e-07	5.34e-06	Human papillomavirus infection
KEGG	6	2.23e-07	5.34e-06	Non-small cell lung cancer
RCTM	6	1.89e-07	5.6e-06	HDR through Homologous Recombination (HRR)
KEGG	6	3.05e-07	5.94e-06	Melanoma
KEGG	6	2.83e-07	5.94e-06	Pancreatic cancer
KEGG	6	2.83e-07	5.94e-06	Glioma
RCTM	5	2.05e-07	6.01e-06	Oncogene Induced Senescence
HPO	6	6.88e-09	6.46e-06	Hypoplastic labia majora
KEGG	6	3.83e-07	6.77e-06	Chronic myeloid leukemia
Process	4	4.4e-08	6.84e-06	DNA replication, synthesis of RNA primer
HPO	7	8.35e-09	6.95e-06	Aplasia/Hypoplasia of the breasts
HPO	9	7.97e-09	6.95e-06	Abnormal uvula morphology
HPO	8	9.55e-09	6.98e-06	Microtia
Process	44	4.87e-08	7.49e-06	Regulation of macromolecule metabolic process
WikiPathways	5	2.05e-07	7.63e-06	Type 2 papillary renal cell carcinoma
WikiPathways	6	2.23e-07	7.9e-06	Melanoma
HPO	7	1.2e-08	8.13e-06	Elbow dislocation
KEGG	5	4.9e-07	8.24e-06	Bladder cancer
InterPro	4	9.41e-09	8.45e-06	GINS, helical bundle-like domain superfamily
RCTM	4	3.13e-07	8.82e-06	Telomere C-strand synthesis initiation
RCTM	6	3.05e-07	8.82e-06	CDK-mediated phosphorylation and removal of Cdc6
Process	6	6.25e-08	9.52e-06	Positive regulation of fibroblast proliferation
HPO	6	1.58e-08	1.02e-05	Atresia of the external auditory canal
WikiPathways	6	3.05e-07	1.04e-05	Head and neck squamous cell carcinoma
WikiPathways	6	3.05e-07	1.04e-05	Non-small cell lung cancer
Keyword	8	1.93e-07	1.08e-05	Dwarfism
HPO	6	2.3e-08	1.34e-05	Abnormal labia majora morphology
Keyword	6	2.61e-07	1.35e-05	Nucleotidyltransferase
WikiPathways	5	4.37e-07	1.36e-05	Bladder cancer
WikiPathways	5	4.9e-07	1.47e-05	ATM signaling pathway
RCTM	19	5.27e-07	1.47e-05	Gene expression (Transcription)
Process	5	9.84e-08	1.48e-05	Positive regulation of G2/M transition of mitotic cell cycle
RCTM	8	5.67e-07	1.56e-05	Mitotic G2-G2/M phases
RCTM	10	6.1e-07	1.64e-05	Transcriptional Regulation by TP53
HPO	8	3.55e-08	1.73e-05	Bifid uvula
Process	41	1.27e-07	1.9e-05	Regulation of cellular metabolic process
RCTM	3	8.08e-07	2.14e-05	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
RCTM	3	8.08e-07	2.14e-05	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6
RCTM	6	8.7e-07	2.14e-05	APC/C-mediated degradation of cell cycle proteins
RCTM	3	8.08e-07	2.14e-05	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
KEGG	6	1.41e-06	2.26e-05	Progesterone-mediated oocyte maturation
WikiPathways	6	8.16e-07	2.36e-05	Pancreatic adenocarcinoma pathway
KEGG	6	1.59e-06	2.42e-05	Prostate cancer
Pfam	4	9.41e-09	2.56e-05	MCM N-terminal domain
HPO	10	6.27e-08	2.64e-05	Delayed skeletal maturation
KEGG	7	1.81e-06	2.64e-05	MicroRNAs in cancer
Process	25	1.95e-07	2.86e-05	Cellular biosynthetic process
Keyword	9	6.13e-07	2.94e-05	Mitosis
HPO	8	7.71e-08	3.05e-05	Craniosynostosis
HPO	7	7.51e-08	3.05e-05	Severe short stature
Process	5	2.35e-07	3.41e-05	Mitotic G2 DNA damage checkpoint signaling
WikiPathways	5	1.24e-06	3.45e-05	TROP2 regulatory signaling
HPO	10	9.16e-08	3.49e-05	Clinodactyly of the 5th finger
HPO	10	9.44e-08	3.49e-05	Deviation of the 5th finger
HPO	12	9.41e-08	3.49e-05	Intrauterine growth retardation
InterPro	8	4.4e-08	3.51e-05	AAA+ ATPase domain
HPO	6	1.02e-07	3.55e-05	Slender long bone
HPO	6	1.02e-07	3.55e-05	Submucous cleft hard palate
Function	13	1.25e-07	3.63e-05	Chromatin binding
WikiPathways	5	1.36e-06	3.66e-05	Photodynamic therapy-induced AP-1 survival signaling
Component	3	8.08e-07	4.03e-05	Cyclin E1-CDK2 complex
Keyword	18	9.31e-07	4.17e-05	ATP-binding
Function	24	1.67e-07	4.57e-05	Nucleotide binding
COMPARTMENTS	3	8.08e-07	4.65e-05	MCM core complex
COMPARTMENTS	3	8.08e-07	4.65e-05	Cyclin E1-CDK2 complex
HPO	6	1.59e-07	4.98e-05	Abnormality of the auditory canal
COMPARTMENTS	11	9.11e-07	4.99e-05	Chromatin
Process	25	3.58e-07	5.15e-05	Organic substance biosynthetic process
Component	67	1.14e-06	5.55e-05	Intracellular anatomical structure
Process	4	4.01e-07	5.71e-05	Positive regulation of DNA-templated DNA replication
HPO	6	1.89e-07	5.76e-05	Clitoral hypertrophy
Function	5	2.35e-07	5.79e-05	Cyclin binding
RCTM	8	2.51e-06	6.04e-05	Neddylation
KEGG	5	4.54e-06	6.36e-05	Renal cell carcinoma
HPO	10	2.53e-07	6.86e-05	Abnormality of skeletal maturation
Process	5	4.9e-07	6.86e-05	Positive regulation of DNA replication
TISSUES	10	1.17e-07	7.08e-05	Uterine cervix
COMPARTMENTS	6	1.33e-06	7.14e-05	Nuclear DNA-directed RNA polymerase complex
KEGG	6	5.38e-06	7.22e-05	Oocyte meiosis
COMPARTMENTS	3	1.41e-06	7.38e-05	Cyclin D1-CDK4 complex
COMPARTMENTS	3	1.41e-06	7.38e-05	MCM8-MCM9 complex
HPO	10	2.9e-07	7.69e-05	Abnormal breast morphology
WikiPathways	6	3.02e-06	7.87e-05	Androgen receptor network in prostate cancer
HPO	4	3.13e-07	7.95e-05	Birth length less than 3rd percentile
RCTM	3	3.37e-06	8.01e-05	PTK6 Regulates Cell Cycle
Process	6	5.86e-07	8.13e-05	Mitotic DNA damage checkpoint signaling
COMPARTMENTS	4	1.63e-06	8.14e-05	Cul2-RING ubiquitin ligase complex
SMART	5	2.05e-07	8.42e-05	Domain present in cyclins, TFIIB and Retinoblastoma
COMPARTMENTS	3	2.25e-06	0.0001	Cyclin A2-CDK2 complex
COMPARTMENTS	65	2.12e-06	0.0001	Cellular anatomical entity
Process	4	7.78e-07	0.00011	DNA replication checkpoint signaling
HPO	11	4.57e-07	0.00011	Clinodactyly
Component	3	2.25e-06	0.00011	Cyclin A2-CDK2 complex
Process	67	8.72e-07	0.00012	Cellular process
WikiPathways	5	4.87e-06	0.00012	Thyroid stimulating hormone (TSH) signaling pathway
RCTM	6	4.9e-06	0.00012	Transcriptional regulation by RUNX2
Component	4	2.61e-06	0.00012	Cul2-RING ubiquitin ligase complex
TISSUES	11	2.66e-07	0.00013	Lymphocytic leukemia cell
Function	19	6.13e-07	0.00014	ATP binding
RCTM	7	6.62e-06	0.00015	G2/M Transition
Process	10	1.1e-06	0.00015	Regulation of protein serine/threonine kinase activity
WikiPathways	4	6.56e-06	0.00016	Tumor suppressor activity of SMARCB1
WikiPathways	3	6.58e-06	0.00016	Dual hijack model of Vif in HIV infection
InterPro	5	2.35e-07	0.00017	Cyclin-like domain
RCTM	5	7.75e-06	0.00018	Diseases of programmed cell death
Process	3	1.41e-06	0.00018	Leading strand elongation
KEGG	6	1.51e-05	0.00019	Gastric cancer
SMART	3	8.08e-07	0.00022	Minichromosome  maintenance proteins
COMPARTMENTS	3	4.8e-06	0.00022	Elongin complex
RCTM	4	1.02e-05	0.00023	Regulation of TP53 Degradation
Keyword	4	5.82e-06	0.00024	Cyclin
Component	6	5.38e-06	0.00024	Nuclear DNA-directed RNA polymerase complex
Function	8	1.31e-06	0.00027	Protein kinase regulator activity
KEGG	6	2.24e-05	0.00028	Hepatitis C
Component	3	6.58e-06	0.00029	Cul5-RING ubiquitin ligase complex
SMART	3	1.41e-06	0.00029	DNA polymerase type-B family
COMPARTMENTS	3	6.58e-06	0.00029	Cul5-RING ubiquitin ligase complex
Function	22	1.48e-06	0.00029	Enzyme binding
Process	7	2.2e-06	0.00029	Regulation of G1/S transition of mitotic cell cycle
KEGG	6	2.56e-05	0.0003	Hepatocellular carcinoma
KEGG	5	2.48e-05	0.0003	Endocrine resistance
Process	11	2.57e-06	0.00033	RNA biosynthetic process
Process	5	2.69e-06	0.00034	G2/M transition of mitotic cell cycle
InterPro	5	5.48e-07	0.00036	Cyclin-like superfamily
RCTM	18	1.73e-05	0.00039	Disease
KEGG	5	3.61e-05	0.0004	HIF-1 signaling pathway
RCTM	4	1.99e-05	0.00044	Defective pyroptosis
NetworkNeighborAL	3	2.25e-06	0.00047	Replication fork arrest, and GINS complex protein
InterPro	4	7.78e-07	0.00047	Cyclin, C-terminal domain
InterPro	3	8.08e-07	0.00047	DNA polymerase alpha/delta/epsilon, subunit B
InterPro	3	8.08e-07	0.00047	GINS subunit, domain A
InterPro	4	7.78e-07	0.00047	DNA/RNA polymerase superfamily
NetworkNeighborAL	3	2.25e-06	0.00047	Cyclin-dependent kinase, regulatory subunit, and Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
NetworkNeighborAL	3	2.25e-06	0.00047	G2 Phase, and Familial retinoblastoma
InterPro	4	1.14e-06	0.00051	Cyclin
HPO	6	2.33e-06	0.00051	Hypoplasia of the maxilla
Function	9	2.84e-06	0.00052	ATP hydrolysis activity
Keyword	4	1.38e-05	0.00054	4Fe-4S
WikiPathways	4	2.56e-05	0.00059	Aryl hydrocarbon receptor pathway
InterPro	3	1.41e-06	0.0006	DNA-directed DNA polymerase, family B, exonuclease domain
WikiPathways	3	2.67e-05	0.0006	H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity
InterPro	3	1.41e-06	0.0006	DNA-directed DNA polymerase, family B
InterPro	3	1.41e-06	0.0006	DNA polymerase, palm domain superfamily
InterPro	3	1.41e-06	0.0006	DNA-directed DNA polymerase, family B, multifunctional domain
HPO	12	2.85e-06	0.00061	Abnormality of the lower urinary tract
InterPro	14	1.85e-06	0.00063	P-loop containing nucleoside triphosphate hydrolase
COMPARTMENTS	6	1.68e-05	0.00073	cullin-RING ubiquitin ligase complex
InterPro	3	2.25e-06	0.00073	DNA polymerase family B, thumb domain
Keyword	10	1.99e-05	0.00074	Host-virus interaction
Process	46	5.99e-06	0.00075	Response to stimulus
Process	6	6.15e-06	0.00076	Regulation of DNA biosynthetic process
HPO	9	3.77e-06	0.00079	Abnormality of the urethra
WikiPathways	3	3.79e-05	0.00082	ID signaling pathway
Process	28	6.79e-06	0.00083	Organelle organization
RCTM	3	3.79e-05	0.00083	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
HPO	9	4.22e-06	0.00087	Dyspnea
Function	4	5.15e-06	0.00088	Cyclin-dependent protein serine/threonine kinase activity
Process	4	7.36e-06	0.00089	Negative regulation of DNA replication
HPO	7	4.43e-06	0.0009	Respiratory distress
Function	22	5.94e-06	0.00094	Transferase activity
HPO	6	4.68e-06	0.00094	Abnormality of the maxilla
Function	20	6.38e-06	0.00096	Ribonucleotide binding
Function	20	6.24e-06	0.00096	Purine nucleotide binding
HPO	6	5.62e-06	0.0011	High, narrow palate
WikiPathways	4	5.35e-05	0.0011	Overlap between signal transduction pathways contributing to LMNA laminopathies
InterPro	3	3.37e-06	0.0011	Transcription factor CBF/NF-Y/archaeal histone domain
Pfam	3	8.08e-07	0.0011	DNA polymerase alpha/epsilon subunit B
KEGG	3	9.99e-05	0.0011	Mismatch repair
Pfam	3	8.08e-07	0.0011	GINS complex protein
NetworkNeighborAL	3	6.58e-06	0.0012	Drug-mediated inhibition of CDK4/CDK6 activity, and Regulation of cardiac muscle tissue regeneration
KEGG	5	0.00013	0.0013	Ubiquitin mediated proteolysis
WikiPathways	5	6.25e-05	0.0013	Spinal cord injury
KEGG	6	0.00013	0.0013	Human cytomegalovirus infection
RCTM	3	5.98e-05	0.0013	Transcription of E2F targets under negative control by DREAM complex
HPO	7	7.29e-06	0.0014	Narrow mouth
KEGG	5	0.00014	0.0014	Measles
Process	3	1.14e-05	0.0014	Mitotic DNA replication checkpoint signaling
RCTM	4	6.93e-05	0.0015	Transcriptional regulation of granulopoiesis
RCTM	2	7.17e-05	0.0015	Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4
RCTM	2	7.17e-05	0.0015	Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4
Keyword	21	4.91e-05	0.0016	Ubl conjugation
Component	13	3.98e-05	0.0017	Nucleolus
HPO	8	9.15e-06	0.0017	Hypospadias
COMPARTMENTS	7	4.2e-05	0.0018	Ubiquitin ligase complex
KEGG	5	0.00018	0.0018	Breast cancer
Component	6	4.42e-05	0.0018	cullin-RING ubiquitin ligase complex
Process	17	1.52e-05	0.0018	Intracellular signal transduction
HPO	11	1.04e-05	0.0019	Cleft palate
Process	6	1.68e-05	0.002	Negative regulation of DNA metabolic process
RCTM	4	9.35e-05	0.002	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
InterPro	4	6.56e-06	0.002	Cyclin, N-terminal
RCTM	3	9.99e-05	0.0021	Telomere Extension By Telomerase
HPO	8	1.25e-05	0.0022	Joint dislocation
Keyword	2	7.17e-05	0.0022	Primosome
COMPARTMENTS	10	5.21e-05	0.0022	Nucleolus
HPO	6	1.4e-05	0.0024	Joint hyperflexibility
Function	3	1.8e-05	0.0025	RNA polymerase II CTD heptapeptide repeat kinase activity
WikiPathways	5	0.00013	0.0026	Measles virus infection
Process	3	2.21e-05	0.0026	Regulation of nuclear cell cycle DNA replication
Component	2	7.17e-05	0.0029	MCM8-MCM9 complex
Function	10	2.09e-05	0.0029	ATP-dependent activity
COMPARTMENTS	2	7.17e-05	0.0029	Cyclin E2-CDK2 complex
COMPARTMENTS	2	7.17e-05	0.0029	Cyclin A1-CDK2 complex
COMPARTMENTS	2	7.17e-05	0.0029	Gamma DNA polymerase complex
Component	2	7.17e-05	0.0029	Cyclin E2-CDK2 complex
Component	2	7.17e-05	0.0029	Gamma DNA polymerase complex
Component	2	7.17e-05	0.0029	Cyclin A1-CDK2 complex
HPO	8	1.75e-05	0.003	Aplasia/hypoplasia involving bones of the lower limbs
HPO	14	2.06e-05	0.0034	Microcephaly
HPO	14	2.24e-05	0.0036	Decreased head circumference
Process	3	3.2e-05	0.0037	Negative regulation of DNA-templated DNA replication
KEGG	3	0.00039	0.0037	Homologous recombination
HPO	11	2.37e-05	0.0038	Abnormal long bone morphology
HPO	6	2.4e-05	0.0038	Camptodactyly of finger
HPO	15	2.5e-05	0.0039	Abnormality of body height
HPO	6	2.65e-05	0.004	Narrow palate
HPO	4	2.77e-05	0.0041	Breast hypoplasia
Component	34	0.00011	0.0041	Cytosol
HPO	7	2.84e-05	0.0042	Retrognathia
HPO	7	2.91e-05	0.0042	Abnormal epiphysis morphology
RCTM	4	0.00021	0.0043	Regulation of APC/C activators between G1/S and early anaphase
WikiPathways	4	0.00022	0.0043	DNA IR-damage and cellular response via ATR
HPO	15	3.03e-05	0.0044	Decreased body weight
Component	2	0.00012	0.0044	Rb-E2F complex
HPO	9	3.09e-05	0.0044	Hypoplastic male external genitalia
Component	2	0.00012	0.0044	VCB complex
WikiPathways	5	0.00023	0.0045	Breast cancer pathway
COMPARTMENTS	2	0.00012	0.0047	Pre-primosome complex
COMPARTMENTS	2	0.00012	0.0047	Rad51B-Rad51C complex
HPO	7	3.55e-05	0.0049	Camptodactyly
RCTM	2	0.00025	0.005	Drug-mediated inhibition of CDK4/CDK6 activity
HPO	15	3.82e-05	0.0051	Aplasia/Hypoplasia of the cerebrum
KEGG	5	0.00056	0.0051	Kaposi sarcoma-associated herpesvirus infection
HPO	7	4.2e-05	0.0055	Abnormal rib morphology
HPO	14	4.17e-05	0.0055	Short stature
Process	4	5e-05	0.0058	DNA-templated DNA replication maintenance of fidelity
RCTM	3	0.00029	0.0058	Transcriptional Regulation by E2F6
WikiPathways	4	0.00033	0.0061	p53 transcriptional gene network
Component	2	0.00018	0.0063	CHRAC
Component	2	0.00018	0.0063	Delta DNA polymerase complex
COMPARTMENTS	2	0.00018	0.0067	Replication fork protection complex
COMPARTMENTS	2	0.00018	0.0067	Delta DNA polymerase complex
RCTM	4	0.00035	0.007	Oxidative Stress Induced Senescence
Keyword	2	0.00025	0.0073	DNA excision
HPO	10	5.8e-05	0.0074	Aplasia/hypoplasia of the extremities
HPO	3	5.98e-05	0.0075	Bronchomalacia
Component	14	0.00023	0.0078	Microtubule cytoskeleton
DISEASES	4	1.38e-05	0.0079	Urinary bladder cancer
HPO	7	6.6e-05	0.0082	Flexion contracture of digit
Process	2	7.17e-05	0.0082	Mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication
Process	2	7.17e-05	0.0082	Recombinational interstrand cross-link repair
HPO	8	6.83e-05	0.0083	Hypoplasia of penis
HPO	16	6.7e-05	0.0083	Aplasia/Hypoplasia involving the central nervous system
Component	2	0.00025	0.0084	Elongin complex
Component	2	0.00025	0.0084	Cul4B-RING E3 ubiquitin ligase complex
COMPARTMENTS	2	0.00025	0.0091	CHRAC
Component	9	0.00029	0.0093	Centrosome
Function	2	7.17e-05	0.0093	MutSbeta complex binding
Function	2	7.17e-05	0.0093	MutLbeta complex binding
HPO	10	9.02e-05	0.0109	Abnormal lower limb bone morphology
Function	11	9.09e-05	0.0109	Kinase binding
HPO	11	9.93e-05	0.0118	Abnormal testis morphology
SMART	2	7.17e-05	0.0118	CDC6, C terminal
COMPARTMENTS	2	0.00033	0.0119	Cul4B-RING E3 ubiquitin ligase complex
HPO	10	0.0001	0.012	Aplasia/Hypoplasia of the mandible
HPO	10	0.0001	0.012	Micrognathia
TISSUES	14	2.98e-05	0.0121	Uterus
HPO	12	0.00011	0.0126	Failure to thrive
KEGG	6	0.0015	0.0132	PI3K-Akt signaling pathway
HPO	6	0.00012	0.0133	Specific learning disability
Process	2	0.00012	0.0134	DNA replication preinitiation complex assembly
Process	2	0.00012	0.0134	Negative regulation of transcription involved in G1/S transition of mitotic cell cycle
HPO	8	0.00012	0.0136	Abnormality of the female genitalia
HPO	6	0.00012	0.0137	Thick vermilion border
WikiPathways	4	0.00077	0.014	CKAP4 signaling pathway map
RCTM	6	0.00073	0.0143	Antigen processing: Ubiquitination & Proteasome degradation
COMPARTMENTS	2	0.00043	0.0151	VCB complex
COMPARTMENTS	3	0.00045	0.0158	SCF ubiquitin ligase complex
Function	59	0.00014	0.0163	Binding
WikiPathways	3	0.00094	0.0166	NRP1-triggered signaling pathways in pancreatic cancer 
Function	34	0.00015	0.0177	Catalytic activity
RCTM	2	0.00091	0.0178	Regulation of BACH1 activity
HPO	11	0.00017	0.0179	Abnormal mandible morphology
COMPARTMENTS	2	0.00053	0.0182	PCNA complex
KEGG	3	0.0021	0.0183	Platinum drug resistance
HPO	7	0.00017	0.0183	Posteriorly rotated ears
RCTM	3	0.00099	0.0191	Vif-mediated degradation of APOBEC3G
HPO	9	0.00019	0.0205	Respiratory insufficiency
HPO	7	0.00019	0.0205	Abnormality of mouth size
HPO	9	0.0002	0.0205	Aplasia/hypoplasia involving bones of the extremities
InterPro	2	7.17e-05	0.0206	Cyclin-A, N-terminal APC/C binding region
InterPro	2	7.17e-05	0.0206	Orc1-like, AAA ATPase domain
InterPro	2	7.17e-05	0.0206	Cdc6, C-terminal
InterPro	2	7.17e-05	0.0206	AAA lid domain
WikiPathways	2	0.0012	0.0212	Homologous recombination
WikiPathways	6	0.0012	0.0212	PI3K-Akt signaling pathway
Process	3	0.00021	0.0228	Mismatch repair
Process	5	0.00021	0.0229	Response to UV
InterPro	4	9.35e-05	0.0232	Ribonuclease H-like superfamily
Process	9	0.00022	0.0236	Positive regulation of transferase activity
HPO	9	0.00023	0.0237	Abnormal penis morphology
HPO	2	0.00025	0.0251	Absent sternal ossification
WikiPathways	3	0.0015	0.0253	DYRK1A
RCTM	2	0.0014	0.0263	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
RCTM	2	0.0014	0.0263	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
Process	2	0.00025	0.027	Nucleotide-excision repair, DNA gap filling
Function	2	0.00025	0.0279	MutSalpha complex binding
InterPro	2	0.00012	0.0286	DNA-directed DNA polymerase, family B, conserved site
Process	3	0.00027	0.0287	Histone phosphorylation
Keyword	2	0.0011	0.0298	Progressive external ophthalmoplegia
DISEASES	11	6.6e-05	0.0303	Organ system cancer
DISEASES	2	7.17e-05	0.0303	Meier-Gorlin syndrome 5
Process	6	0.00029	0.0306	Regulation of chromosome organization
WikiPathways	3	0.0019	0.0307	AMP-activated protein kinase signaling
HPO	9	0.00032	0.0317	Cryptorchidism
HPO	10	0.00033	0.0321	Abnormal calvaria morphology
HPO	2	0.00033	0.0321	Multiple mitochondrial DNA deletions
HPO	2	0.00033	0.0321	Brain neoplasm
RCTM	2	0.0018	0.0326	Translesion synthesis by REV1
SMART	2	0.00025	0.0341	Cyclins are a family of proteins that control the progression of cells through the cell cycle by activating cyclin-dependent kinase (Cdk) enzymes.
Process	4	0.00033	0.0347	Cellular response to UV
Process	2	0.00033	0.0349	Positive regulation of nuclear cell cycle DNA replication
Process	4	0.00034	0.0356	Regulation of mitotic metaphase/anaphase transition
HPO	16	0.00038	0.036	Abnormal cerebral morphology
RCTM	2	0.002	0.0361	Translesion synthesis by POLI
RCTM	2	0.002	0.0361	Removal of the Flap Intermediate from the C-strand
RCTM	2	0.002	0.0361	Translesion synthesis by POLK
Process	4	0.00035	0.0368	Protein localization to chromosome
WikiPathways	2	0.0024	0.0385	TP53 network
Component	2	0.0012	0.0386	Cul4A-RING E3 ubiquitin ligase complex
Process	19	0.00039	0.0401	Regulation of catalytic activity
RCTM	3	0.0023	0.0406	Cdc20:Phospho-APC/C mediated degradation of Cyclin A
NetworkNeighborAL	2	0.00025	0.0422	Error-prone translesion synthesis
DISEASES	2	0.00012	0.0422	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis
DISEASES	2	0.00012	0.0422	Isolated growth hormone deficiency type IA
HPO	15	0.00048	0.043	Abnormality of the respiratory system
Component	2	0.0014	0.0433	ATAC complex
DISEASES	12	0.00015	0.0448	Cancer
RCTM	2	0.0027	0.0452	Aberrant regulation of mitotic exit in cancer due to RB1 defects
Component	3	0.0015	0.0452	SCF ubiquitin ligase complex
HPO	3	0.00052	0.0463	Tracheomalacia
HPO	3	0.00052	0.0463	Facial diplegia
HPO	2	0.00053	0.0466	Nocturia
Component	12	0.0016	0.0478	Chromatin
TISSUES	11	0.00014	0.0481	Embryo
TISSUES	6	0.00014	0.0481	Chronic lymphocytic leukemia cell
KEGG	4	0.0059	0.0499	Human immunodeficiency virus 1 infection
